Quarterly Revenue Growth
Total net revenue for Q4 2025 increased 20.1% year-over-year to RMB 1.38 billion (from RMB 1.15 billion), meeting prior guidance and outpacing the industry.
Full Year Revenue Recovery
Total net revenue for FY2025 rose 26.7% year-over-year to RMB 4.3 billion (from RMB 3.39 billion), marking a return to growth after 2024 declines.
Skincare-Led Expansion
Skincare brands drove growth: Q4 skincare revenue grew 51.9% YoY and accounted for 61.1% of Q4 net revenues; FY2025 skincare revenue grew 63.5% YoY and contributed 53% of total net revenues.
Improved Profitability and Margin Trends
Q4 GAAP net income of RMB 3.0 million (net income margin 0.2%) versus a Q4 FY2024 net loss of RMB 378.8 million; FY2025 net loss narrowed to RMB 92.4 million (loss margin 2.2%) from RMB 710.2 million (20.9%). Gross margin improved to 78.2% for FY2025 (from 77.1%).
Non-GAAP Turnaround
FY2025 delivered a non-GAAP net income of RMB 8.4 million (non-GAAP net income margin 0.2%) versus a non-GAAP net loss of RMB 128.2 million in the prior year, representing a return to non-GAAP profitability.
Operating Expense Discipline
Total operating expenses in Q4 decreased 15.6% YoY to RMB 1.08 billion, with operating expenses as a percentage of revenue improving to 78.6% from 111.8% in the prior year period; G&A as % of revenue fell to 5.4% from 8.7%.
Product & Brand Highlights Driven by R&D
R&D-led innovations and recognition: Galenic launches (VB serum and Couture Revelation cream) drove strong sales and awards; Dr. Wu launched PDRN serum and was recognized as Douyin’s annual growth breakthrough brand. R&D spend increased (Q4 R&D +47.5% YoY to RMB 38.8 million) supporting new product pipeline.
No Goodwill Impairment This Year
There was no impairment of goodwill in FY2025 versus a RMB 403.1 million goodwill impairment in the prior year, materially improving operating results.
Positive Near-Term Revenue Guidance
Q1 2026 revenue guidance of RMB 958.6 million to RMB 1.08 billion, representing an expected YoY increase of approximately 15% to 30%.